Search results
Gene Panel Predicts Early HER2+ Breast Cancer Prognosis
Medscape· 7 days agoPatients with early-stage HER2+ breast cancer could soon be offered less intensive treatment based...
Is Vaginal Estrogen Safe in Breast Cancer Survivors?
Medscape· 4 days agoVaginal estrogen therapy appears to be safe after early breast cancer in patients with HR-negative tumors and those with HR-positive tumors concurrently...
Can diet help with advanced breast cancer? All indications are positive, researchers say
Medical Xpress· 4 days agoThe outcomes are from a small study by researchers at the University of Rochester Medical Center and...
When should you get a mammogram? Austin doctors explain breast cancer screening guidelines
Austin American-Statesman via Yahoo News· 5 days agobreast tissue, which can increase the call-back rates. Having a 3-D mammogram instead of a 2-D can...
29 Celebrities Who Have Had Breast Cancer
SheKnows via Yahoo News· 6 days agoFrom A-list celebrities to the people in our own lives, breast cancer can can truly happen to anyone — and the stats show it. After skin cancer ...
No Improvement in OS With Atezolizumab in Relapsing TNBC
Medscape· 7 days agoEarly relapsing disease has again shown the limitations of immunotherapy in triple-negative breast ...
Juncell Therapeutics Announces Clinical Data of GC203 TIL therapy in Ovarian Cancer at ASCO 2024
KTLA-TV Los Angeles· 3 days ago(Juncell Therapeutics), a clinical-stage biotech developing innovative Tumor-Infiltrating Lymphocyte (TIL) therapies for cancers, announced latest clinical ...
BriaCell Doubles Progression-Free-Survival (PFS) and Reports Clinical Benefit Data at ASCO 2024
Digital Journal· 3 days ago83% intracranial objective response rate (iORR) with Bria-IMT™ in heavily pretreated advanced breast cancer patients with CNS metastasesMedian progression ...
Roche Cancer Drug Gets Breakthrough Therapy Designation - Ligand Pharmaceuticals (NASDAQ:LGND), ANI...
Benzinga· 5 days agoRoche (OTC: RHHBY) obtained a Breakthrough Therapy Designation for its investigational oral therapy...
Biotechs Zero in on New Pancreatic Therapies as Global Pancreatic Cancer Market Expected Reach to...
Morningstar· 3 days agoWith its low survival rates and limited treatment options, pancreatic cancer remains a significant focus of medical research and development efforts. A ...